Publisher: Elsevier
Phages have sparked attention as an appealing way to eradicate bacteria serving as a possible treatment option for diseases caused by antibiotic- and multidrug-resistant pathogens. However, the susceptibility of phages to acidic pH, enzymatic activity, and short in vivo half-life largely restricts their use. Phages loaded into biomaterials will be protected from harmful environmental elements while being released for therapeutic action. Furthermore, biomaterials can react to an emerging infection before clinical symptoms appear, substantially improving the patient’s prognosis. Thus phage-impre ...